M&A is poised for a comeback. Here’s how this AI-powered dealmaking startup is getting in on the action.December 19, 2024
Aeterna Zentaris Completes Key DETECT-Trial Phase By Investing.com Stocks June 13, 2024 Aeterna Zentaris Inc. (NASDAQ:), a biopharmaceutical company specializing in endocrine-related therapy and diagnostics, announced today the completion of the last…